abstract |
The present invention provides compounds of formula I n nand pharmaceutically acceptable salts thereof.n n The formula I compounds inhibit tyrosine kinase activity of such as TrkA, TrkB, TrkC, Jak2, Jak3 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases. |